Biopharmaceuticals are large and complex molecules manufactured using biological sources, which can provide specific treatment to patients suffering from several pathologies. Amongst biopharmaceuticals, monoclonal antibodies (mAbs) represent today’s most common class of biological therapies, with more than 1,200 mAbs-based drugs candidates currently in development for the treatment of several diseases including rheumatoid arthritis, multiple sclerosis, COVID-19 and many different types of cancer. Industrial mAbs production presents the sizeable hurdles of purification costs and environmental …


Read More


Notizie del Consiglio Nazionale delle Ricerche

Dichiarazione di accessibilità

Note Legali

Privacy Policy